ConforMIS Announces Pricing of Its Initial Public Offering
(Thomson Reuters ONE) -
BEDFORD, Mass., July 1, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. announced today
the pricing of its initial public offering of 9,000,000 shares of common stock
at a public offering price of $15.00 per share, before underwriting discounts.
All of the shares in the offering are being sold by ConforMIS. In addition,
ConforMIS has granted the underwriters an option to purchase up to 1,350,000
additional shares of common stock at the public offering price, less the
underwriting discount. ConforMIS' common stock has been approved for listing on
the NASDAQ Global Select Market and is expected to begin trading under the
symbol "CFMS" on July 1, 2015. The offering is expected to close on July
7, 2015, subject to customary closing conditions.
J.P. Morgan and Deutsche Bank Securities are acting as joint book-running
managers for the offering. Wells Fargo Securities, Canaccord Genuity and
Oppenheimer & Co. are acting as co-managers.
This offering is being made only by means of a prospectus. A copy of the
prospectus may be obtained from: J.P. Morgan Securities LLC, Attention:
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or
by telephone at (866) 803-9204; or Deutsche Bank Securities Inc., Attention:
Prospectus Group, 60 Wall Street, New York, NY 10005-2836, or by email to
prospectus.cpdg(at)db.com, or by telephone at +1 (800) 503-4611.
This press release shall not constitute an offer to sell or the solicitation of
an offer to buy, nor shall there be any sale of, these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification of these securities under the securities
laws of any such state or jurisdiction.
About ConforMIS
ConforMIS is a medical technology company that uses its proprietary iFit Image-
to-Implant technology platform to develop, manufacture and sell joint
replacement implants that are individually sized and shaped, or customized, to
fit each patient's unique anatomy. ConforMIS offers a broad line of customized
knee implants designed to restore the natural shape of a patient's knee.
CONTACT: Investor Contact:
Paul Weiner
ir(at)conformis.com
(781) 345-9001
Media Contacts:
Bill Berry
Berry & Company Public Relations
Bberry(at)berrypr.com
(212) 258-8881
Lynn Granito
Berry & Company Public Relations
Lgranito(at)berrypr.com
(212) 253-8881
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: ConforMIS via GlobeNewswire
[HUG#1933259]
Datum: 01.07.2015 - 06:23 Uhr
Sprache: Deutsch
News-ID 404126
Anzahl Zeichen: 3339
contact information:
Town:
Bedford
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ConforMIS Announces Pricing of Its Initial Public Offering"
steht unter der journalistisch-redaktionellen Verantwortung von
ConforMIS (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
